Fresh Tracks Therapeutics, Inc.
Fresh Tracks Therapeutics, Inc. (FRTX) Revenue
Annual & quarterly revenue history · segment & region breakdown
FRTX · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsFresh Tracks Therapeutics, Inc. trailing twelve-month (TTM) revenue is $0.01B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Fresh Tracks Therapeutics, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Fresh Tracks Therapeutics, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Fresh Tracks Therapeutics, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
FRTX revenue · 4 questionsFRTX's trailing twelve-month (TTM) revenue is $0.01B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Fresh Tracks Therapeutics, Inc. SEC filings · GAAP · Fresh Tracks Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026